IS5827A - Múskarín gerandefni og mótlyf - Google Patents

Múskarín gerandefni og mótlyf

Info

Publication number
IS5827A
IS5827A IS5827A IS5827A IS5827A IS 5827 A IS5827 A IS 5827A IS 5827 A IS5827 A IS 5827A IS 5827 A IS5827 A IS 5827A IS 5827 A IS5827 A IS 5827A
Authority
IS
Iceland
Prior art keywords
muskrin
antidotes
agonists
muskrin agonists
Prior art date
Application number
IS5827A
Other languages
English (en)
Icelandic (is)
Inventor
Grewal Gurmit
Toy-Palmer Anna
Cai Xiong
Mark Latham George
Original Assignee
Ucb, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb, S.A. filed Critical Ucb, S.A.
Publication of IS5827A publication Critical patent/IS5827A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IS5827A 1998-08-18 2001-01-26 Múskarín gerandefni og mótlyf IS5827A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
IS5827A true IS5827A (is) 2001-01-26

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5827A IS5827A (is) 1998-08-18 2001-01-26 Múskarín gerandefni og mótlyf

Country Status (30)

Country Link
US (5) US6093724A (de)
EP (1) EP1112272B1 (de)
JP (1) JP2002523416A (de)
KR (1) KR20010072784A (de)
CN (1) CN1312812A (de)
AR (1) AR020199A1 (de)
AT (1) ATE227724T1 (de)
AU (1) AU750566B2 (de)
BG (1) BG105256A (de)
BR (1) BR9913072A (de)
CA (1) CA2340946A1 (de)
CO (1) CO5130018A1 (de)
DE (1) DE69903961T2 (de)
EE (1) EE200100096A (de)
ES (1) ES2191455T3 (de)
HK (1) HK1038918A1 (de)
HU (1) HUP0103203A3 (de)
ID (1) ID27544A (de)
IL (1) IL141050A0 (de)
IS (1) IS5827A (de)
NO (1) NO20010804L (de)
NZ (1) NZ509762A (de)
PE (1) PE20000988A1 (de)
PL (1) PL346247A1 (de)
RU (1) RU2219179C2 (de)
SK (1) SK1892001A3 (de)
TR (1) TR200100462T2 (de)
WO (1) WO2000011001A1 (de)
YU (1) YU13301A (de)
ZA (1) ZA200100978B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20031013A3 (en) * 2000-10-19 2004-03-17 Pfizer Products Inc. Bridged piperazine derivatives
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) * 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) * 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
MX2009010175A (es) * 2007-03-23 2009-10-12 Abbott Lab Derivados de acetamida y carboxamida de aza-adamantano y metodos de uso de los mismos.
EP2497771A1 (de) * 2007-03-23 2012-09-12 Abbott Laboratories 4-substituierte Azaadamantan-Derivate und Verfahren zu ihrer Verwendung
WO2010145208A1 (en) * 2009-06-19 2010-12-23 Abbott Laboratories Diazahomoadamantane derivatives and methods of use thereof
ES2742728T3 (es) 2009-07-22 2020-02-17 PureTech Health LLC Composiciones para el tratamiento de trastornos mejorados por la activación del receptor muscarínico
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (de) 2010-04-23 2015-10-28 Cytokinetics, Inc. Bestimmte aminopyrimidine und aminotriazine, zusammensetzungen daraus und verfahren zu ihrer verwendung
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
EP2619205B1 (de) * 2010-09-23 2017-05-17 AbbVie Bahamas Ltd. Monohydrat eines azaadamantanderivates
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
EP3651762B1 (de) 2017-07-12 2024-07-03 Vanderbilt University Antagonisten des muskarinischen acetylcholinrezeptors m4
JP7270989B2 (ja) 2017-10-20 2023-05-11 ヴァンダービルト ユニバーシティー ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト
EP3732163A4 (de) * 2017-12-20 2021-07-14 Vanderbilt University Antagonisten des muskarinischen acetylcholinrezeptors m4
PT3856182T (pt) 2018-09-28 2026-03-10 Karuna Therapeutics Inc Composições e métodos para o tratamento de perturbações melhoradas pela ativação dos recetores muscarínicos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IL88156A (en) * 1987-11-13 1997-02-18 Novo Nordisk As Azacyclic compounds their preparation and pharmaceutical compositions containing them
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
TR199800780T2 (xx) * 1995-11-02 1998-07-21 Neurosearch A/S Kayna�m�� tropan t�revleri, haz�rlan��lar� ve kullan�mlar�.
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release

Also Published As

Publication number Publication date
BG105256A (en) 2001-11-30
CO5130018A1 (es) 2002-02-27
BR9913072A (pt) 2001-05-15
TR200100462T2 (tr) 2001-09-21
US6323194B1 (en) 2001-11-27
US6251916B1 (en) 2001-06-26
HK1038918A1 (zh) 2002-04-04
ZA200100978B (en) 2002-02-05
PE20000988A1 (es) 2000-09-30
KR20010072784A (ko) 2001-07-31
EP1112272B1 (de) 2002-11-13
EE200100096A (et) 2002-06-17
ES2191455T3 (es) 2003-09-01
DE69903961T2 (de) 2003-07-03
WO2000011001A1 (en) 2000-03-02
US20020045617A1 (en) 2002-04-18
NZ509762A (en) 2002-12-20
SK1892001A3 (en) 2001-11-06
DE69903961D1 (de) 2002-12-19
ID27544A (id) 2001-04-12
RU2219179C2 (ru) 2003-12-20
US6555550B1 (en) 2003-04-29
JP2002523416A (ja) 2002-07-30
US6093724A (en) 2000-07-25
AR020199A1 (es) 2002-05-02
NO20010804L (no) 2001-04-11
YU13301A (sh) 2005-06-10
EP1112272A1 (de) 2001-07-04
HUP0103203A3 (en) 2002-10-28
IL141050A0 (en) 2002-02-10
NO20010804D0 (no) 2001-02-16
US6423842B1 (en) 2002-07-23
CN1312812A (zh) 2001-09-12
HUP0103203A2 (hu) 2002-01-28
AU750566B2 (en) 2002-07-25
ATE227724T1 (de) 2002-11-15
CA2340946A1 (en) 2000-03-02
PL346247A1 (en) 2002-01-28
AU5775899A (en) 2000-03-14

Similar Documents

Publication Publication Date Title
NO20032753L (no) Forbindelse og anvendelse derav
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
DK1130965T4 (da) Kombinationer til herbicider og modgifte
NO991150D0 (no) Pyrazolopyrimidiner og pyrazolotriaziner
DK1076704T3 (da) IL-2-selektive agonister og antagonister
DK0815861T3 (da) Sulfonamider og anvendelse deraf
NO20022334L (no) Ny sammensetning og anvendelse
ID23076A (id) Popok sekali pakai
NO992430D0 (no) R°rkobling
NO20006488D0 (no) Sammensetning og anvendelse
PT102179A (pt) Mortuorio movel
DE69822917D1 (de) Abtast- und Halteschaltung
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20010804L (no) Muskariniske agonister og antagonister
DK199900820A (da) Ørehænger
DE69917697D1 (de) Schaukel- und Gleitmechanismus
NO20013237D0 (no) 3,3-biarylpiperidin og 2,2-biarylmorfolinderivater
NO20010660D0 (no) Isolator
EE200000432A (et) Naftüül- ja aniliidasendatud sulfoonamiidid
DK0910369T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder
NO983802D0 (no) Benzothiofener, formuleringer inneholdende samme og fremgangsmÕter
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20006626D0 (no) Beleggingsmiddel og anvendelse herav
NO984829L (no) Operasjonsutstyr og bruks-fremgangsmÕte
NO20003268D0 (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse